Rosiglitazone ameliorates senescence and promotes apoptosis in ovarian cancer induced by olaparib. Wang Z, Gao J, Ohno Y, Liu H, et al. Cancer Chemother Pharmacol 2020 Jan 6. pii: 10.1007/s00280-019-04025.

Read + Share

Amedeo Smart

Independent Medical Education

Wang Z, Gao J, Ohno Y, Liu H, et al. Rosiglitazone ameliorates senescence and promotes apoptosis in ovarian cancer induced by olaparib. Cancer Chemother Pharmacol 2020 Jan 6. pii: 10.1007/s00280-019-04025.
PMID: 31907647